Literature DB >> 3090844

Gas exchange and lung morphology after surfactant replacement in experimental adult respiratory distress syndrome induced by repeated lung lavage.

P Berggren, B Lachmann, T Curstedt, G Grossmann, B Robertson.   

Abstract

Severe respiratory insufficiency was induced in adult guinea pigs by repeated lung lavage. The animals were then ventilated for 75 min with 100% O2, insufflation pressure 28/6-8 cmH2O (2.7/0.6-0.8 kPa), frequency 30/min, and 33% inspiration time. One group of animals (I) was treated with protein-depleted porcine surfactant, prepared by a combination of sucrose-gradient centrifugation, heating to 90 degrees C, and chloroform/methanol extraction. Another group (II) received the phospholipid fraction of porcine surfactant, isolated from minced lungs by chloroform/methanol extraction and liquid-gel chromatography. Surfactant was administered in two 1-ml doses (lipid concentration 90 mg/ml) instilled via the tracheal cannula about 15 and 45 min after the lavage procedure. Non-treated, lavaged animals served as controls. After 75 min of ventilation, control values for PaO2 and PaCO2 were 13.3 +/- 6.8 and 6.8 +/- 2.3 kPa (mean +/- s.d.), respectively. The corresponding values in Group I of surfactant-treated animals were 52.9 +/- 7.7 and 4.4 +/- 1.1 kPa, in Group II 53.5 +/- 7.3 and 4.8 +/- 1.3 kPa (P less than 0.02-0.002). The two groups of surfactant-treated animals also had significantly improved alveolar air expansion in histological sections, as reflected by increased alveolar volume density (0.67 +/- 0.05 and 0.62 +/- 0.11 vs 0.45 +/- 0.08 in controls; P less than 0.002). The benefits of surfactant replacement in this experimental model were thus similar to those previously observed in animal models of neonatal surfactant deficiency as well as in babies with respiratory distress syndrome (RDS). Our data suggest that surfactant replacement might have a therapeutic effect also in clinical adult RDS.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3090844     DOI: 10.1111/j.1399-6576.1986.tb02423.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  14 in total

1.  Factors influencing the clinical response to surfactant replacement therapy in babies with severe respiratory distress syndrome. Collaborative European Multicentre Study Group.

Authors: 
Journal:  Eur J Pediatr       Date:  1991-04       Impact factor: 3.183

2.  Effect of prone position on regional shunt, aeration, and perfusion in experimental acute lung injury.

Authors:  Torsten Richter; Giacomo Bellani; R Scott Harris; Marcos F Vidal Melo; Tilo Winkler; Jose G Venegas; Guido Musch
Journal:  Am J Respir Crit Care Med       Date:  2005-05-18       Impact factor: 21.405

Review 3.  Porcine-derived lung surfactant. A review of the therapeutic efficacy and clinical tolerability of a natural surfactant preparation (Curosurf) in neonatal respiratory distress syndrome.

Authors:  L R Wiseman; H M Bryson
Journal:  Drugs       Date:  1994-09       Impact factor: 9.546

4.  Optimisation of positive end-expiratory pressure by forced oscillation technique in a lavage model of acute lung injury.

Authors:  Raffaele L Dellacà; Emanuela Zannin; Peter Kostic; Marie Andersson Olerud; Pasquale P Pompilio; Goran Hedenstierna; Antonio Pedotti; Peter Frykholm
Journal:  Intensive Care Med       Date:  2011-04-01       Impact factor: 17.440

Review 5.  Surfactant replacement therapy.

Authors:  M J Kresch; W H Lin; R S Thrall
Journal:  Thorax       Date:  1996-11       Impact factor: 9.139

Review 6.  Surfactant therapy for acute lung injury and acute respiratory distress syndrome.

Authors:  Krishnan Raghavendran; D Willson; R H Notter
Journal:  Crit Care Clin       Date:  2011-07       Impact factor: 3.598

7.  Exposure of the hydrophobic components of porcine lung surfactant to oxidant stress alters surface tension properties.

Authors:  N Gilliard; G P Heldt; J Loredo; H Gasser; H Redl; T A Merritt; R G Spragg
Journal:  J Clin Invest       Date:  1994-06       Impact factor: 14.808

8.  In vivo evaluation of the inhibitory capacity of human plasma on exogenous surfactant function.

Authors:  B Lachmann; E P Eijking; K L So; D Gommers
Journal:  Intensive Care Med       Date:  1994       Impact factor: 17.440

Review 9.  Pharmacotherapy of acute lung injury and acute respiratory distress syndrome.

Authors:  Krishnan Raghavendran; Gloria S Pryhuber; Patricia R Chess; Bruce A Davidson; Paul R Knight; Robert H Notter
Journal:  Curr Med Chem       Date:  2008       Impact factor: 4.530

10.  Effect of surfactant replacement on Pneumocystis carinii pneumonia in rats.

Authors:  E P Eijking; G J van Daal; R Tenbrinck; A Luijendijk; J F Sluiters; E Hannappel; B Lachmann
Journal:  Intensive Care Med       Date:  1991       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.